69 related articles for article (PubMed ID: 9369430)
21. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR
Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043
[TBL] [Abstract][Full Text] [Related]
22. Interaction of the erythropoietin and stem-cell-factor receptors.
Wu H; Klingmüller U; Besmer P; Lodish HF
Nature; 1995 Sep; 377(6546):242-6. PubMed ID: 7545788
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor.
Hanazono Y; Sasaki K; Nitta H; Yazaki Y; Hirai H
Biochem Biophys Res Commun; 1995 Mar; 208(3):1060-6. PubMed ID: 7535525
[TBL] [Abstract][Full Text] [Related]
24. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
[TBL] [Abstract][Full Text] [Related]
25. Enriched levels of erythropoietin in human umbilical cord blood stimulate hematopoietic progenitor cells.
Lawlor GF; Tauchi T; Ohyashiki K; Matsumiya T
J Biochem Mol Biol Biophys; 2002 Feb; 6(1):65-70. PubMed ID: 12186785
[TBL] [Abstract][Full Text] [Related]
26. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
Feldman L; Frazier JG; Sytkowski AJ
Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
[TBL] [Abstract][Full Text] [Related]
27. Interleukins and colony stimulating factors in human myeloid leukemia cell lines.
Hassan HT; Drexler HG
Leuk Lymphoma; 1995 Dec; 20(1-2):1-15. PubMed ID: 8750618
[TBL] [Abstract][Full Text] [Related]
28. Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7.
Miura Y; Kirito K; Komatsu N
Acta Haematol; 1998; 99(3):180-4. PubMed ID: 9587401
[TBL] [Abstract][Full Text] [Related]
29. Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells.
Okuno Y; Suzuki A; Ichiba S; Takahashi T; Nakamura K; Hitomi K; Sasaki R; Tada K; Imura H
Cancer; 1990 Oct; 66(7):1544-51. PubMed ID: 2169992
[TBL] [Abstract][Full Text] [Related]
30. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.
Menier C; Guillard C; Cassinat B; Carosella ED; Rouas-Freiss N
Leukemia; 2008 Mar; 22(3):578-84. PubMed ID: 18059484
[TBL] [Abstract][Full Text] [Related]
31. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA
Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936
[TBL] [Abstract][Full Text] [Related]
32. Effects of erythropoietin and recombinant cytokines on colony formation and self-renewal by erythroid burst-forming units and granulocyte-macrophage progenitors from mobilized peripheral blood progenitor cells.
Zheng B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):6-12. PubMed ID: 12513828
[TBL] [Abstract][Full Text] [Related]
33. Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study Group.
Takeshita A; Shinjo K; Higuchi M; Miyawaki S; Takemoto Y; Kishimoto Y; Saito K; Takuchi H; Kuriyama K; Kimura Y; Asou N; Takahashi M; Hotta T; Kanamaru A; Ueda R; Ohno R
Br J Haematol; 2000 Jan; 108(1):55-63. PubMed ID: 10651724
[TBL] [Abstract][Full Text] [Related]
34. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
35. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
Hirata J; Sato H; Takahira H; Shiokawa S; Endo T; Nishimura J; Katsuno M; Masuda S; Sasaki R; Fukumaki Y
Leukemia; 1990 May; 4(5):365-72. PubMed ID: 2167410
[TBL] [Abstract][Full Text] [Related]
36. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
37. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
38. Expression of the erythropoietin receptor on a human myeloma cell line.
Okuno Y; Takahashi T; Suzuki A; Ichiba S; Nakamura K; Hitomi K; Sasaki R; Imura H
Biochem Biophys Res Commun; 1990 Aug; 170(3):1128-34. PubMed ID: 2167671
[TBL] [Abstract][Full Text] [Related]
39. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J; Yuan B; Hu W; Lodish H
Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
[TBL] [Abstract][Full Text] [Related]
40. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
